Results 261 to 270 of about 615,781 (294)
Some of the next articles are maybe not open access.
Der Internist, 2020
Diabetes mellitus is a chronic disease that develops against the background of insulin deficiency as a result of a decrease in its production or impaired receptor perception by target cells.
D. Ziegler
semanticscholar +2 more sources
Diabetes mellitus is a chronic disease that develops against the background of insulin deficiency as a result of a decrease in its production or impaired receptor perception by target cells.
D. Ziegler
semanticscholar +2 more sources
Muscle and Nerve, 2020
We investigated the risk of carpal tunnel syndrome (CTS) in diabetic polyneuropathy (DPN).
H. Moon+4 more
semanticscholar +1 more source
We investigated the risk of carpal tunnel syndrome (CTS) in diabetic polyneuropathy (DPN).
H. Moon+4 more
semanticscholar +1 more source
New Insights Into Diabetic Polyneuropathy
JAMA, 2003Patients with complaints of numbness, tingling, and dysesthesias in the toes and feet are frequently referred to neurologists. Often, the only objective evidence for peripheral nerve dysfunction in these patients is limited to small-caliber sensory nerve fibers.
John W. Griffin+2 more
openaire +3 more sources
Neuromodulation (Malden, Mass.), 2020
Up until now there is little data about the pain relieving effect of different frequency settings in DRGS. The aim of this study was to compare the pain relieving effect of DRGS at low‐, mid‐, and high‐frequencies and Sham‐DRGS in an animal model of ...
E. Koetsier+6 more
semanticscholar +1 more source
Up until now there is little data about the pain relieving effect of different frequency settings in DRGS. The aim of this study was to compare the pain relieving effect of DRGS at low‐, mid‐, and high‐frequencies and Sham‐DRGS in an animal model of ...
E. Koetsier+6 more
semanticscholar +1 more source
Diabetic polyneuropathy: Bridging the translational gap
Journal of the peripheral nervous system, 2020Clinical trials for diabetic polyneuropathy (DPN) have failed to identify therapeutic impacts that have arrested or reversed the disorder, despite a long history.
Masaki Kobayashi, D. Zochodne
semanticscholar +1 more source
Biomarkers for the Development and Progression of Diabetic Polyneuropathy
Neuroscience and Behavioral Physiology, 2020To study the diagnostic potential of brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGFA) and their high affinity receptors (TrkB, VEGFR2) in the development and progression of diabetic polyneuropathy.The main group consisted of 65 patients with diabetes mellitus and confirmed DPN.
T. A. Filimonova, Yu. V. Karakulova
openaire +4 more sources
Epidemiology of polyneuropathy in diabetes and prediabetes
2014Diabetic distal symmetric sensorimotor polyneuropathy (DSPN) represents a major health problem, associated with excruciating neuropathic pain, increased morbidity and impaired quality of life. The understanding of its epidemiology is difficult due to methodological issues.
Aaron I. Vinik+3 more
openaire +3 more sources
Postural Stability in Diabetic Polyneuropathy
Diabetes Care, 1995OBJECTIVE To examine whether sensory changes in lower limbs associated with diabetic sensory polyneuropathy compromise postural stability in different visual sensory conditions. RESEARCH DESIGN AND METHODS The presence and seventy of sensory ...
Normand Teasdale+4 more
openaire +3 more sources
Plasma Norepinephrine in Sensory Diabetic Polyneuropathy
Diabetes Care, 1993OBJECTIVE To examine whether changes in circulating norepinephrine are associated with the sensory disturbances of diabetic polyneuropathy. Experimental studies have indicated that NE can excite sprouts from injured nerves, producing pain. RESEARCH DESIGN AND METHODS
Tsigos, Constantine+4 more
openaire +4 more sources